Anke van den Berg

Prof. Anke van den Berg is a Professor of Molecular Pathogenesis of Malignant B-Cell Lymphoma at the University of Groningen's Faculty of Medical Sciences. She holds positions as a Clinical Molecular Biologist in Pathology at the UMCG, and leads research within the Stem cells, Aging, Leukemia and Lymphoma (SALL) program. Her work focuses on noncoding RNAs, genomic aberrations, and therapy resistance in lymphomas. She supervises PhD students and sits on editorial and review committees.

Education: PhD (cum laude) in Molecular Pathology (1996), followed by postdoctoral roles and academic promotions. Research funding comes from KWF, EU, NWO, and SKOG.

Research interests include Hodgkin/non-Hodgkin lymphoma pathogenesis, microRNA roles, and molecular diagnostics. She develops biomarkers for therapy guidance and investigates targeted therapies in lung cancer. Her lab is part of the North Netherlands Oncology Center (NNOC).

Awards: Not explicitly listed, but her work has received significant research grants and international collaborations.

Advising/Grants: Supervised 45+ PhDs, oversees multiple funded projects, and collaborates globally. Active in professional roles like ZonMW review committees and MicroRNA editorial boards.

Labs/Teams: Leads the Lymphoma Research Group Groningen and collaborates with Translational Immunology Groningen (TRIGR) and Molecular Oncology (MO) teams.